Product NDC: | 10631-118 |
Proprietary Name: | Absorica |
Non Proprietary Name: | isotretinoin |
Active Ingredient(s): | 40 mg/1 & nbsp; isotretinoin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10631-118 |
Labeler Name: | Ranbaxy Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021951 |
Marketing Category: | NDA |
Start Marketing Date: | 20120608 |
Package NDC: | 10631-118-31 |
Package Description: | 3 BLISTER PACK in 1 BOX (10631-118-31) > 10 CAPSULE in 1 BLISTER PACK (10631-118-69) |
NDC Code | 10631-118-31 |
Proprietary Name | Absorica |
Package Description | 3 BLISTER PACK in 1 BOX (10631-118-31) > 10 CAPSULE in 1 BLISTER PACK (10631-118-69) |
Product NDC | 10631-118 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | isotretinoin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120608 |
Marketing Category Name | NDA |
Labeler Name | Ranbaxy Laboratories Inc. |
Substance Name | ISOTRETINOIN |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |